📄 Description (English)
NVIDIA BioNeMo contains a vulnerability where a user could cause a deserialization of untrusted data. A successful exploit of this vulnerability might lead to code execution, denial of service, information disclosure, and data tampering.
🤖 AI Executive Summary
NVIDIA BioNeMo Framework contains a critical deserialization vulnerability (CVE-2026-24165) that could allow attackers to execute arbitrary code, cause denial of service, or tamper with data. With a CVSS score of 7.8 and no patch currently available, this poses an immediate risk to Saudi organizations using this framework for biomedical research and AI applications. The vulnerability requires urgent mitigation through compensating controls until patches are released.
📄 Description (Arabic)
🤖 AI Intelligence Analysis Analyzed: Apr 29, 2026 02:48
🇸🇦 Saudi Arabia Impact Assessment
Saudi healthcare organizations, research institutions (King Abdulaziz University, KAUST), and government biomedical research centers using NVIDIA BioNeMo for drug discovery, genomics analysis, or AI-driven medical research face significant risk. The vulnerability could compromise sensitive patient data, research datasets, and intellectual property. ARAMCO's research divisions and healthcare sector entities under SEHA oversight are particularly vulnerable. The lack of available patches elevates risk for critical infrastructure and regulated healthcare entities subject to SAMA and NCA oversight.
🏢 Affected Saudi Sectors
Healthcare & Biomedical Research
Government Research Institutions
Energy Sector (ARAMCO research divisions)
Academic & University Research Centers
Pharmaceutical & Drug Discovery
Genomics & Life Sciences
AI/ML Research Organizations
🎯 MITRE ATT&CK Techniques
⚖️ Saudi Risk Score (AI)
8.2
/ 10.0
🔧 Remediation Steps (English)
IMMEDIATE ACTIONS:
1. Inventory all NVIDIA BioNeMo Framework deployments across your organization
2. Isolate affected systems from production networks if possible, or implement strict network segmentation
3. Disable BioNeMo services if not critical to operations; migrate to alternative frameworks if feasible
4. Implement input validation and sanitization for all data sources feeding into BioNeMo
5. Enable comprehensive logging and monitoring of BioNeMo processes
COMPENSATING CONTROLS:
6. Deploy Web Application Firewalls (WAF) to detect and block malicious serialized objects
7. Implement strict access controls limiting BioNeMo access to authenticated, authorized users only
8. Use network segmentation to isolate BioNeMo systems from sensitive data repositories
9. Deploy runtime application self-protection (RASP) solutions if available
10. Implement file integrity monitoring on BioNeMo installation directories
DETECTION RULES:
11. Monitor for suspicious deserialization attempts using YARA rules targeting Java/Python serialization magic bytes (AC ED 00 05 for Java)
12. Alert on unexpected child processes spawned by BioNeMo services
13. Monitor for unusual network connections from BioNeMo processes
14. Track modifications to BioNeMo configuration files and libraries
15. Subscribe to NVIDIA security advisories for patch availability and apply immediately upon release
🔧 خطوات المعالجة (العربية)
الإجراءات الفورية:
1. قم بحصر جميع نشرات إطار عمل NVIDIA BioNeMo في جميع أنحاء المنظمة
2. عزل الأنظمة المتأثرة عن شبكات الإنتاج إن أمكن، أو تطبيق تقسيم شبكة صارم
3. تعطيل خدمات BioNeMo إذا لم تكن حرجة للعمليات؛ الهجرة إلى أطر عمل بديلة إن أمكن
4. تطبيق التحقق من صحة المدخلات والتطهير لجميع مصادر البيانات التي تغذي BioNeMo
5. تفعيل السجلات الشاملة ومراقبة عمليات BioNeMo
الضوابط التعويضية:
6. نشر جدران الحماية لتطبيقات الويب (WAF) للكشف عن الكائنات المسلسلة الضارة وحجبها
7. تطبيق ضوابط وصول صارمة تحد من وصول BioNeMo للمستخدمين المصرح لهم فقط
8. استخدام تقسيم الشبكة لعزل أنظمة BioNeMo عن مستودعات البيانات الحساسة
9. نشر حلول حماية التطبيقات في وقت التشغيل (RASP) إن توفرت
10. تطبيق مراقبة سلامة الملفات على أدلة تثبيت BioNeMo
قواعد الكشف:
11. مراقبة محاولات فك التسلسل المريبة باستخدام قواعد YARA التي تستهدف بايتات السحر للتسلسل
12. التنبيه على العمليات الفرعية غير المتوقعة التي تنتجها خدمات BioNeMo
13. مراقبة الاتصالات الشبكية غير العادية من عمليات BioNeMo
14. تتبع التعديلات على ملفات ومكتبات تكوين BioNeMo
15. الاشتراك في تنبيهات أمان NVIDIA وتطبيق التصحيحات فوراً عند توفرها
📋 Regulatory Compliance Mapping
🟢 NCA ECC 2024
ECC 2024 A.5.1 - Information Security Policies (secure development practices)
ECC 2024 A.6.1 - Organization of Information Security (vendor risk management)
ECC 2024 A.12.6 - Technical Vulnerability Management (patch management)
ECC 2024 A.14.2 - Secure Development and Maintenance (third-party component security)
🔵 SAMA CSF
Governance & Risk Management - Third-party risk assessment
Information & Cybersecurity - Vulnerability management and patch management
Operational Resilience - Business continuity for critical systems
Incident Management - Detection and response capabilities
🟡 ISO 27001:2022
ISO 27001:2022 A.5.1 - Policies for information security
ISO 27001:2022 A.8.1 - Asset management and inventory
ISO 27001:2022 A.12.6 - Management of technical vulnerabilities
ISO 27001:2022 A.14.2 - Secure development, testing, and maintenance
ISO 27001:2022 A.16.1 - Planning and preparation for incident management
🟣 PCI DSS v4.0.1
PCI DSS 6.2 - Ensure security patches are installed within defined timeframe
PCI DSS 11.2 - Run automated vulnerability scans regularly
PCI DSS 12.3 - Establish security policies for third-party service providers
🔗 References & Sources 3
📦 Affected Products / CPE 1 entries
nvidia:bionemo_framework